Brought to you by 
Teva acquires OPG Group's Pharmachemie for $87mm cash
13 Jul 1999
Executive Summary
Public company Teva Pharmaceutical Industries Ltd., (Israel's largest drug company) acquires the Dutch OPG Group's generic drug division Pharmachemie BV for about $87mm cash (final amount to be determined at the anticipated June 30th closing).
Deal Industry
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Teva acquires OPG Group's Pharmachemie for $87mm cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice